Navigation Links
Health researchers in McGill network receive $35.5 million in CIHR funding
Date:5/9/2008

This release is available in French.

The Honourable Tony Clement, federal Minister of Health announced May 7, 2008, funding from the Canadian Institutes of Health Research (CIHR) for 764 health research projects across Canada, totalling more than $298 million. Researchers at McGill University and four of its affiliated institutions the McGill University Health Centre (MUHC), the Montreal Neurological Institute (MNI), the Jewish General Hospital (JGH) and the Douglas Mental Health University Institute received more than $35.5 million, one of the highest allotments in the country.

These grants, allocated between July 2007 and January 2008, fund more than 80 cutting-edge research projects in fields as diverse as arthritis, Alzheimers disease, multiple forms of cancer, nutrition, epilepsy, medical imaging, health care delivery, infertility, heart disease, cell biology and pharmacology, to name but a few.

Funding from CIHR, in the hands of our researchers, leads to knowledge-creation, improved quality of life, and even cures for many of the diseases and conditions that affect Canadians and people the world over," said Denis Thrien, McGills Vice-Principal (Research and International Relations). "McGill, in partnership with CIHR, will continue to provide our researchers with the support they need to pursue their important investigations."

The Canadian Institutes of Health Research (CIHR) is the Government of Canada's agency for health research. CIHR's mission is to create new scientific knowledge and to catalyze its translation into improved health, more effective health services and products, and a strengthened Canadian health care system. Composed of 13 Institutes, CIHR provides leadership and support to more than 11,000 health researchers and trainees across Canada.

We are immensely proud of the researchers at the MNI, said Dr. D
'/>"/>

Contact: Mark Shainblum
mark.shainblum@mcgill.ca
514-398-1385
McGill University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Passport Health Disaster Response Experts Offer Services to Myanmar Volunteers
2. LCA-Vision to Present at the Bank of America 2008 Health Care Conference
3. CVS Caremark Honors Heroes in Womens Health
4. Sunrise to Present at Bank of America Healthcare Conference
5. Mike Turner, Virginia Congressional Candidate, Starts Healthcare Countdown
6. PA Budget Secretary Says Future Retiree Health Care Costs Estimated at $8.5 Billion
7. MedCath Corporation to Present at the Banc of America Securities 2008 Health Care Conference
8. DRAXIS Health Reports Results for the First Quarter of 2008
9. Medical Mutual of Ohio, CareWorks Build a Healthier Workforce
10. Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies
11. HealthSouth Board Re-Elected at Annual Shareholder Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...wswire/ -- The diabetes population in the United S...d annual medical spending on the disease is projec...y, according to a study published in the December ...Diabetes ® Program (NCDP), a program of Novo ...the University of Chicago. ,, According to the ...
(Date:11/26/2009)...bdate (TM) has been shown in studies to be effecti...aused by an overload of copper, and certain metast...ever, is known about how the drug works at the mol...University researchers now has provided an invalua...und to copper-loaded metallochaperones. The drug s...
(Date:11/26/2009)...l rollercoaster, study finds , , THURSDA...ctor meets the jubilant sports fan. , A new stu...o root for the winning team -- enjoy the greatest ... victory was in doubt, producing feelings of worry...ving weekend as you,re glued to the TV set, watchi...
(Date:11/26/2009)...he Live Life Again Center, a practice offering we...number of physicians who are taking advantage of ...dividuals who are interested in surgical weight lo...tilizing Facebook to share before-and-after photos...nity. , Dallas, TX (Vocus...
(Date:11/26/2009)...ons announces a highly effective and unconventiona...to make an economic recovery. , ...he type of challenge that could send ailing holida...vid Benton, business growth expert and author of t...The Rfactor Intensive . “Fear is one of th...
Breaking Medicine News(10 mins):Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
...R, Md., Oct. 17 Delmarva Foundation is,pleased to... of Columbia,Hospital Trustee "Driving Quality" Aw... whose leadership has inspired the hospital to con... health,care that is safe, effective, patient-cent...
... finding points to genes preventing slumber, scien... They may not toss and turn, but even fish can get...lp sleepless humans. , A team at Stanford Universi...g may help scientists in their efforts to learn mo...
...ce May 2007, a new drug has been available for the... 2 in Germany: exenatide (trade name: Byetta), whi... drug was developed for patients who cannot suffic...diabetic agent or insulin. Like insulin, exenatide...
...ore than 20 years ago, doctors at Mattel Children,... transplant on a baby girl who was born without a ...deficiency. It marked the first time a bone marrow...ack of the young girl when her family moved away b...
...yang Technological University (NTU) and Insightra ...edical device, Ree-Trakt, is released for sale in ...e by NTU that has been developed and patented in a...tion flexibility and optimal exposure of view in a...
...tal venous tumor thrombus (PVTT) is a crucial fact...hepatocellular carcinoma (HCC). It often leads to ...ver, and can increase portal venous blood pressure... failure. However, there is no effective useful th...
Other Medicine News:Health News:Delmarva Foundation Announces 2007 Trustee Awardees 2Health News:Benefit of exenatide has not yet been proven 2Health News:Benefit of exenatide has not yet been proven 3Health News:Benefit of exenatide has not yet been proven 4Health News:Reunion with patient inspires follow-up study on treatment for DiGeorge syndrome 2Health News:Reunion with patient inspires follow-up study on treatment for DiGeorge syndrome 3Health News:NTU and Insightra Medical Inc. release their first joint venture medical device 2
(Date:11/25/2009)...Newswire/ -- Cempra Pharmaceuticals Inc. today ann...hief executive officer, will present at the Piper ... a.m. EST, December 1, 2009, at The New York Palac...ide an overview of the company,s two leading antib...resistant pathogens including MRSA. ,, About C...
(Date:11/25/2009)...v. 25 HeartWare Internat...innovator and provider of less invasive, miniaturi...ng the treatment of advanced heart failure, today ... presentation at the 21st Annual Piper Jaffray Hea...ecember 2, 2009. The conference is being held at t...
(Date:11/24/2009)...e-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX ), ...tic disorders, announced today that it has filed a..., the patent infringement lawsuit brought against ...iled in the United States District Court in Indian...t the stay remain in effect while the United State...
Breaking Medicine Technology:HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Mount Sinai researchers to test first gene therapy For Alzheimers patients 61540 1Mount Sinai researchers to test first gene therapy For Alzheimers patients 61540 2New funds for Rice M D Anderson program 61536 1New funds for Rice M D Anderson program 61536 22 UNH faculty receive 241 4M in CAREER grants from NSF 10769 12 UNH faculty receive 241 4M in CAREER grants from NSF 10769 2
...chodilation and symptom control ... 20 A newly published study presents,data demonst...onary Disease,(COPD), including emphysema and chro...chodilation and symptom control when treated with ...alation solution,(Perforomist(TM) Inhalation Solut...
...mployer Claims Suggests a Benefit,of Anti-Tumor Ne...yees with Inflammatory Bowel...ysis of the,Active Ulcerative Colitis Trials (ACT ...rcent of patients with moderately to severely acti...infliximab) achieved,clinical response regardless ...
Other Medicine Technology:Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 2Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 3Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 4Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 5Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 6Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 7New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 2New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 3New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 4New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 5New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 6New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 7New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 8
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: